PCN140 IMPACT OF TUMOR RESPONSE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH VELCADE/MELPHALAN/PREDNISONE (V-MP)- RESULTS FROM THE VISTA TRIAL
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74390-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)74390-4/fulltext
Title :
PCN140 IMPACT OF TUMOR RESPONSE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH VELCADE/MELPHALAN/PREDNISONE (V-MP)- RESULTS FROM THE VISTA TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74390-4&doi=10.1016/S1098-3015(10)74390-4
First page :
Section Title :
Open access? :
No
Section Order :
317